Hepatitis, Viral, Human  >>  GSK2878175  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK2878175 / GSK
NCT01879462: A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Completed
1
47
RoW
GSK2878175, Placebo
GlaxoSmithKline
Hepatitis C, Chronic
01/14
01/14
NCT02014571: Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Completed
1
37
US
GSK2878175, Placebo
GlaxoSmithKline, PPD
Hepatitis C, Chronic
07/14
01/15

Download Options